drugset
drugset / Trial / NCT01444924

Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery

NCT01444924 ↗

Phase 2 Completed 75 enrolled University of Wisconsin, Madison
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

This study is a single-center, randomized, placebo-controlled, double-blind clinical trial. The purpose of this study is to evaluate the impact of pre-operative transverses abdominis plane (TAP) blocks on post-operative analgesia in patients undergoing robotic surgery for gynecologic cancers.

Timeline

Start
2011-09
Primary completion
2013-02
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.25 % Other
Subject Bupivacaine Other / unclassified 30 ml Other

Indications

female reproductive organ cancer